Log in to save to my catalogue

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a re...

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4061526

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data

About this item

Full title

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2014-06, Vol.14 (1), p.310-310, Article 310

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Mucormycosis is a rare and potentially fatal fungal infection occurring primarily in severely immunosuppressed patients. Because it is so rare, reports in the literature are mainly limited to case reports or small case series. The aim of this study was to evaluate inpatient mortality, length of stay (LOS), and costs among a matched sample of high-r...

Alternative Titles

Full title

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4061526

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4061526

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/1471-2334-14-310

How to access this item